サイクリンD3
“D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy”. J. Pathol. 187 (5): 573–81. (1999). doi:10.1002/(SICI)1096-9896(199904)187:5<573::AID-PATH289>3.0.CO;2-H. PMID 10398124.
“Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells”. Mol. Cell. Biol. 20 (15): 5690–9. (2000). doi:10.1128/MCB.20.15.5690-5699.2000. PMC 86042. PMID 10891505. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86042/.
“NPDC-1, a regulator of neural cell proliferation and differentiation, interacts with E2F-1, reduces its binding to DNA and modulates its transcriptional activity”.
Oncogene 19 (43): 5000–9. (2000). doi:10.1038/sj.onc.1203843. PMID 11042687.
“Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors”. Exp. Hematol. 29 (4): 490–8. (2001). doi:10.1016/S0301-472X(01)00619-1. PMID 11301189.
“Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence”. Oncogene 20 (16): 2000–9. (2001). doi:10.1038/sj.onc.1204375. PMID 11360184.
“Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon”. Gastroenterology 120 (7): 1680–8. (2001). doi:10.1053/gast.2001.24880. PMID 11375949.